| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/00005650-199809000-00006 |
| P698 | PubMed publication ID | 9749657 |
| P2093 | author name string | Kramer BS | |
| Potosky AL | |||
| Harlan LC | |||
| Klabunde CN | |||
| P433 | issue | 9 | |
| P921 | main subject | prostate cancer | Q181257 |
| P304 | page(s) | 1337-1348 | |
| P577 | publication date | 1998-09-01 | |
| P1433 | published in | Medical Care | Q15762119 |
| P1476 | title | Trends and black/white differences in treatment for nonmetastatic prostate cancer | |
| P478 | volume | 36 |
| Q42347821 | A call for papers: disparities in health |
| Q57108539 | Active Surveillance for Prostate Cancer: Are We Failing Latino Patients at a Large Safety Net Hospital? |
| Q46586239 | African American men significantly underestimate their risk of having prostate cancer at the time of biopsy |
| Q34288005 | Are HIV-infected men vulnerable to prostate cancer treatment disparities? |
| Q35955484 | Cancer stage at diagnosis and survival among persons with Social Security Disability Insurance on Medicare |
| Q74083954 | Changes in radical prostatectomy and radiation therapy rates for African Americans and whites |
| Q35888211 | Comorbidities, treatment and ensuing survival in men with prostate cancer |
| Q46656860 | Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer |
| Q57387101 | Effectiveness of platinum-based chemotherapy among elderly patients with advanced ovarian cancer |
| Q39794293 | Ethnic variation in return to baseline values of patient-reported outcomes in older prostate cancer patients |
| Q46410199 | Explaining the difference in prostate cancer mortality rates between white and black men in the United States |
| Q59193486 | Factors Associated With Initial Therapy for Clinically Localized Prostate Cancer: Prostate Cancer Outcomes Study |
| Q33559123 | Factors associated with initial treatment and survival for clinically localized prostate cancer: results from the CDC-NPCR Patterns of Care Study (PoC1) |
| Q55312114 | Factors influencing prostate cancer patterns of care: An analysis of treatment variation using the SEER database. |
| Q34722941 | Genetic susceptibility to prostate cancer in men of African descent: implications for global disparities in incidence and outcomes |
| Q37078086 | Health disparities in staging of SEER-medicare prostate cancer patients in the United States |
| Q43544429 | Hidden barriers between knowledge and behavior: the North Carolina prostate cancer screening and treatment experience |
| Q37139352 | Hospital racial composition and the treatment of localized prostate cancer |
| Q37149323 | Impact of androgen deprivation therapy on racial/ethnic disparities in the survival of older men treated for locoregional prostate cancer. |
| Q35248385 | Improving access and quality of care for African Americans with advanced cancer |
| Q46253574 | Initial treatment for prostate carcinoma in relation to comorbidity and symptoms |
| Q36111135 | Interventions to improve decision making and reduce racial and ethnic disparities in the management of prostate cancer: a systematic review |
| Q37152796 | Investigating Black-White differences in prostate cancer prognosis: A systematic review and meta-analysis. |
| Q38823794 | Is prostate cancer different in black men? Answers from 3 natural history models. |
| Q81585851 | Marriage and ethnicity predict treatment in localized prostate carcinoma |
| Q30887750 | Measuring the quality of diabetes care using administrative data: is there bias? |
| Q57566985 | Medical and non-medical determinants of prostate cancer management |
| Q39717558 | Medical care cost of patients with prostate cancer |
| Q50129214 | Minorities, women, and clinical cancer research: the charge, promise, and challenge |
| Q91706754 | National Trends in the Utilization of Androgen Deprivation Therapy for Very Low Risk Prostate Cancer |
| Q35123274 | Nonmedical factors in treatment selection |
| Q73614919 | Overall and disease-specific survival after radical prostatectomy: geographic uniformity |
| Q73466592 | Patterns of prostate cancer treatment by clinical stage and age |
| Q38000053 | Prostate cancer epidemiology in the United States |
| Q38683379 | Prostate cancer in men of African origin. |
| Q35564143 | Prostate cancer patients' refusal of cancer-directed surgery: a statewide analysis. |
| Q46266975 | Race and outcomes: is this the end of the beginning for minority health research? |
| Q35184342 | Race independently predicts prostate specific antigen testing frequency following a prostate carcinoma diagnosis |
| Q40141263 | Race, Socioeconomic Position, and Physical Health: A Descriptive Analysis |
| Q33610509 | Race, healthcare access and physician trust among prostate cancer patients |
| Q34731569 | Race/ethnicity and the receipt of watchful waiting for the initial management of prostate cancer |
| Q90108136 | Racial Disparities in the Presentation, Early Definitive Surgical Treatment, and Mortality Among Men Diagnosed with Poorly Differentiated/Undifferentiated Non-metastatic Prostate Cancer in the USA |
| Q46964693 | Racial differences in breast cancer screening among women from 65 to 74 years of age: trends from 1987-1993 and barriers to screening |
| Q34742544 | Racial differences in initial treatment for clinically localized prostate cancer. Results from the prostate cancer outcomes study |
| Q46851485 | Racial differences in treatment of early-stage prostate cancer |
| Q36503071 | Racial disparities in cancer therapy: did the gap narrow between 1992 and 2002? |
| Q46733585 | Racial disparity in primary and adjuvant treatment for nonmetastatic prostate cancer: SEER-Medicare trends 1991 to 1999. |
| Q33606053 | Racial variation in the pattern and quality of care for prostate cancer in the USA: mind the gap |
| Q37164773 | Racial variation in the quality of surgical care for prostate cancer |
| Q35000598 | Racial/ethnic disparities in survival among men diagnosed with prostate cancer in Texas |
| Q46710173 | Radiation therapy in non-surgically-treated nonmetastatic prostate cancer: geographic and demographic variation |
| Q73930531 | Radical prostatectomy: geographic and demographic variation |
| Q81612089 | Sociodemographic factors associated with postprostatectomy radiotherapy |
| Q33855680 | Socioeconomic factors and breast carcinoma in multicultural women |
| Q37353501 | Socioeconomic status and prostate cancer incidence and mortality rates among the diverse population of California |
| Q79133392 | Stage at diagnosis and survival in a multiethnic cohort of prostate cancer patients |
| Q58799382 | The comparative effectiveness of decision aids in diverse populations with early stage prostate cancer: a study protocol for a cluster-randomized controlled trial in the NCI Community Oncology Research Program (NCORP), Alliance A191402CD |
| Q37136654 | The contribution of cancer incidence, stage at diagnosis and survival to racial differences in years of life expectancy |
| Q36611932 | The role of socio-economic status in the decision making on diagnosis and treatment of oesophageal cancer in The Netherlands |
| Q37426733 | Trends and racial differences in the use of androgen deprivation therapy for metastatic prostate cancer |
| Q36520517 | Trends in prostate cancer in the United States |
| Q36743301 | Use of adjuvant 5-fluorouracil and radiation therapy after gastric cancer resection among the elderly and impact on survival |
| Q33977514 | Use of androgen deprivation therapy for metastatic prostate cancer in older men. |
| Q35069577 | Variation in quality of care among older men with localized prostate cancer |
| Q78744482 | Vulnerability and the patient-practitioner relationship: the roles of gatekeeping and primary care performance |
| Q36433781 | Why do men choose one treatment over another?: a review of patient decision making for localized prostate cancer |
Search more.